These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19459858)

  • 1. Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue.
    Hirata E; Arakawa Y; Shirahata M; Yamaguchi M; Kishi Y; Okada T; Takahashi JA; Matsuda M; Hashimoto N
    Cancer Sci; 2009 Aug; 100(8):1451-9. PubMed ID: 19459858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells.
    Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Nagai R; Kudo C; Sasada M; Kodama H; Fukai F
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
    Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
    Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact and functional aspects of tenascin-C expression during glioma progression.
    Herold-Mende C; Mueller MM; Bonsanto MM; Schmitt HP; Kunze S; Steiner HH
    Int J Cancer; 2002 Mar; 98(3):362-9. PubMed ID: 11920587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas.
    Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR
    BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma.
    Iyoda T; Fujita M; Fukai F
    Front Immunol; 2020; 11():610096. PubMed ID: 33362799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive Progression in Glioblastoma Cells through Potentiated Activation of Integrin α5β1 by the Tenascin-C-Derived Peptide TNIIIA2.
    Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Sasada M; Nagai R; Kudo C; Otsuka K; Kamiya S; Kodama H; Fukai F
    Mol Cancer Ther; 2019 Sep; 18(9):1649-1658. PubMed ID: 31189613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
    Wang SD; Rath P; Lal B; Richard JP; Li Y; Goodwin CR; Laterra J; Xia S
    Oncogene; 2012 Dec; 31(50):5132-43. PubMed ID: 22310282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
    Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
    Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
    Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
    J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.
    Sarkar S; Zemp FJ; Senger D; Robbins SM; Yong VW
    Neuro Oncol; 2015 Aug; 17(8):1095-105. PubMed ID: 25646025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
    Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
    Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
    J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCAPG2 facilitates glioblastoma cells' malignancy and xenograft tumor growth via HBO1 activation by phosphorylation.
    Wu J; Li L; Jiang G; Zhan H; Zhu X; Yang W
    Cell Tissue Res; 2021 Feb; 383(2):693-706. PubMed ID: 32897418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference with NTSR1 Expression Exerts an Anti-Invasion Effect via the Jun/miR-494/SOCS6 Axis of Glioblastoma Cells.
    Ou-Yang Q; He X; Yang A; Li B; Xu M
    Cell Physiol Biochem; 2018; 49(6):2382-2395. PubMed ID: 30261490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression.
    Miroshnikova YA; Mouw JK; Barnes JM; Pickup MW; Lakins JN; Kim Y; Lobo K; Persson AI; Reis GF; McKnight TR; Holland EC; Phillips JJ; Weaver VM
    Nat Cell Biol; 2016 Dec; 18(12):1336-1345. PubMed ID: 27820599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance.
    Wu ZB; Cai L; Lin SJ; Xiong ZK; Lu JL; Mao Y; Yao Y; Zhou LF
    Neuro Oncol; 2013 Sep; 15(9):1264-75. PubMed ID: 23828241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.